跳至主要内容
临床试验/ACTRN12617001560381
ACTRN12617001560381终止未知

Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Locally Advanced Rectal Cancer: A Multicentre Randomised Study (DYNAMIC-RECTAL)

AGITG0 个研究点目标入组 250 人开始时间: 2017年11月15日最近更新:

试验速览

阶段
未知
状态
终止
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Aged 18 years of age and over
  • 2.Subjects with locally advanced rectal cancer treated with curative intent
  • 3.Subjects treated with pre-operative long course chemo-radiation and surgery
  • 4.CT scan of chest/abdomen/pelvis prior to commencing pre-operative chemo-radiation demonstrating no metastatic disease
  • 5.A tumour sample (from the pre-treatment biopsy or surgery specimen is available for molecular testing within 35 days after surgery
  • 6.Fit for adjuvant (post surgery) chemotherapy

排除标准

  • 1.History of another primary cancer within the last 3 years (with the exception of non-melanoma skin cancer and carcinoma in situ).
  • 2.Patients with multiple primary colorectal cancers
  • 3.Inadequate bone marrow, kidney and liver function, as determined by blood tests
  • 4.Evidence of active infection
  • 5.Clinically significant cardiovascular disease
  • 6.Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the study requirements

研究者

发起方
AGITG

相似试验

终止
2 期
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Early Stage Pancreatic Cancer: A Multicentre Randomised Study (DYNAMIC- Pancreas)Cancer - PancreaticPancreatic Cancer
ACTRN12618000335291Australasian Gastro-Intestinal Trials Group118
招募中
2 期
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study (DYNAMIC-III)Colorectal Cancer
ACTRN12617001566325Australasian Gastro-Intestinal Trials Group1,000
进行中(未招募)
1 期
Circulating tumour DNA based decision for adjuvant treatment in colon cancer stage II evaluation (CIRCULATE) AIO-KRK-0217Colon cancer stage IIMedDRA version: 21.0Level: PTClassification code 10009954Term: Colon cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10038049Term: Rectal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2018-003691-12-DETechnische Universität Dresden4,812
招募中
3 期
Circulating tumour DNA based decision for adjuvant treatment in colon cancer stage II evaluation (CIRCULATE), AIO-KRK-0217
DRKS00018695Technische Universität Dresden4,812
招募中
1 期
CIRCULATEcolon cancer stage II, rectal cancer stage IIMedDRA version: 21.0Level: PTClassification code: 10009954Term: Colon cancer stage II Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10038049Term: Rectal cancer stage II Class: 100000004864
CTIS2023-506715-18-00Technische Universitat Dresden140